Skip to content

Study · Animal study (in vivo) · pig · 2001

2 results

Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.

Thanou M, Verhoef JC, Verheijden JH, Junginger HE

Pharmaceutical research1 Jun 2001Cited by 49 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Pharmacokinetics

    In pigs, intrajejunal octreotide without polymer had bioavailability of 1.7 +/- 1.1% (mean +/- SE).

    In plain wordsIn pigs, octreotide given into the jejunum without polymer had bioavailability of 1.7 +/- 1.1%.

    Peptide
    Octreotide
    Outcome
    Not applicableBioavailability at 10 mg
    Study

    pign = 6

    Juvenile female pigs with jejunal stoma and fistula
    Outcome group
    Pharmacokinetics · Pharmacology
    Studied dose
    10 mg · intrajejunalAs given in this study (pig).

    Measurements

    Bioavailability
    1.7%
    10 mg octreotide without polymer
    Standard error
    1.1%
    10 mg octreotide without polymer

    Source sentences

    Summary
    Intrajejunal administration of 10 mg octreotide without any polymer (control solution) resulted in F values of 1.7 +/- 1.1% (mean +/- SE).
    3 context sentences
    Summary · context
    Six female pigs (body weight, 25 kg) were operated to induce a stoma at the beginning of their jejunum and to insert an in-dwelling fistula for intrajejunal (IJ) administration of the formulations.
    Summary · context
    One week after surgery the pigs received IJ octreotide solution administrations with or without TMC at pH 7.4 or chitosan HCl at pH 5.5.
    Summary · context
    For determining bioavailability (F) values, the pigs also received an octreotide solution intravenously (IV).
  2. 02AnimalAnimal study (in vivo)Pharmacokinetics

    In pigs, intrajejunal octreotide solution had bioavailability of 0.5 +/- 0.6% at 5 mg.

    In plain wordsIn pigs, 5 mg octreotide given into the jejunum had bioavailability of 0.5 +/- 0.6%.

    Peptide
    Octreotide
    Outcome
    Not applicableBioavailability at 5 mg
    Study

    pign = 6

    Juvenile female pigs with jejunal stoma and fistula
    Outcome group
    Pharmacokinetics · Pharmacology
    Studied dose
    5 mg · intrajejunalAs given in this study (pig).

    Measurements

    Bioavailability
    0.5%
    5 mg octreotide solution
    Reported variability
    0.6%
    5 mg octreotide solution

    Source sentences

    Summary
    IJ administration of 5 mg octreotide solutions resulted in low F values of 0.5 +/- 0.6%,
    3 context sentences
    Summary · context
    Six female pigs (body weight, 25 kg) were operated to induce a stoma at the beginning of their jejunum and to insert an in-dwelling fistula for intrajejunal (IJ) administration of the formulations.
    Summary · context
    One week after surgery the pigs received IJ octreotide solution administrations with or without TMC at pH 7.4 or chitosan HCl at pH 5.5.
    Summary · context
    For determining bioavailability (F) values, the pigs also received an octreotide solution intravenously (IV).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:36 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.